Show simple item record

dc.creatorWang, Chunyan
dc.creatorLi, Wentao
dc.creatorDrabek, Dubravka
dc.creatorOkba, Nisreen M.A.
dc.creatorvan Haperen, Rien
dc.creatorOsterhaus, Albert D.M.E.
dc.creatorvan Kuppeveld, Frank J.M.
dc.creatorHaagmans, Bart L.
dc.creatorGrosveld, Frank
dc.creatorBosch, Berend Jan
dc.date.accessioned2020-07-22T22:23:09Z
dc.date.available2020-07-22T22:23:09Z
dc.date.created2020-05-04
dc.identifier.issn2041-1723spa
dc.identifier.otherhttps://www.nature.com/articles/s41467-020-16256-yspa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/10999
dc.format.extent6 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.publisherScience Directeng
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectAnticuerposspa
dc.titleA human monoclonal antibody blocking SARS-CoV-2 infectionspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.identifier.doihttps://doi.org/10.1038/s41467-020-16256-yspa
dc.description.abstractenglishThe emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record